Merck Announces $70 Billion Investment to Expand U.S. Manufacturing and R&D

Reuters12-20
Merck Announces $70 Billion Investment to Expand U.S. Manufacturing and R&D

Merck & Co. Inc. has announced plans to invest more than $70 billion in capital and R&D spending in the United States over the next several years, including at least $12 billion for capital expenditures. The company is expanding its manufacturing footprint with new facilities in Virginia, Kansas, and Delaware, which are expected to create 1,200 full-time jobs and support 15,000 construction jobs. These investments aim to boost domestic production and innovation, strengthen the U.S. position in biopharmaceutical development, and improve access to affordable medicines for Americans.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merck & Co. Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251219167722) on December 19, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment